Ipca Labs Partners BRL to Develop Next-Generation Subcutaneous Biologics for Cancer, Autoimmune Diseases sheeba farhat13 Jun 2026 11:00 AM ISTMumbai: Ipca Laboratories Ltd. has entered into a definitive global licensing agreement with Bhami Research Laboratory Pvt. Ltd. (BRL), gaining access...
Centre Approves Price Hike for Cisplatin, Carboplatin to Tackle Nationwide Cancer Drug Shortage Susmita Roy11 Jun 2026 5:45 PM ISTNew Delhi: The central government has granted approval for an increase in the prices of four critical drug formulations, including two widely used...
Alembic Pharma Gets USFDA Tentative Nod for Nubeqa Generic Darolutamide MD Bureau14 May 2026 8:32 PM ISTNew Delhi: Alembic Pharmaceuticals has received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New...
Aurobindo Arm CuraTeQ Secures Health Canada Nod for Cancer Biosimilar Bevqolva sheeba farhat4 May 2026 11:00 PM ISTNew Delhi: Aurobindo Pharma on Friday said its arm CuraTeQ Biologics has received a compliance notice from Health Canada's Biologics and...
Intas Pharma Barred from Using Cancer Drug Brand BEVATAS Similar to Sun Pharma's BEVETEX Susmita Roy3 April 2026 3:23 PM ISTNew Delhi: In a significant ruling on pharmaceutical trademark infringement, the Delhi High Court in the case of Sun Pharma Laboratories Limited vs...
Sanofi's Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version sheeba farhat29 March 2026 10:30 AM ISTBengaluru: French drugmaker Sanofi said on Friday ​the European ​Medicines Agency has recommended the approval of ​a subcutaneous version of its blood...
Roche Breast Cancer Drug Giredestrant Fails Late-Stage Trial Goal sheeba farhat10 March 2026 10:56 PM ISTFrankfurt: Roche's shares dropped more than 5% on Monday as the Swiss drugmaker failed to show that its promising breast cancer drug candidate...
Servier to Buy Day One Biopharma for USD 2.5B, Adds USFDA-Approved Brain Tumor Drug Ojemda sheeba farhat8 March 2026 11:00 AM ISTBengaluru: French drugmaker Servier said on Friday it would buy U.S.-based Day One Biopharmaceuticals for about USD 2.5 billion, expanding its brain...
All Cancer Drugs Regulated Under DPCO, 131 Formulations Price-Capped: Govt Susmita Roy15 Feb 2026 2:00 PM ISTNew Delhi: The Government has clarified that all oncology medicines are covered under the Drugs (Prices Control) Order, 2013 (DPCO, 2013) either...
CDSCO Clears AstraZeneca's Imfinzi (Durvalumab) for Additional Cancer Indication in India Farhat Nasim10 Feb 2026 8:10 PM ISTNew Delhi: AstraZeneca Pharma India Ltd on Tuesday said it has received permission from India's drug regulator to market Durvalumab solution for...
Gland Pharma Gets USFDA Nod for Zoledronic Acid Injection for Cancer-Related Bone Disorders sheeba farhat7 Feb 2026 8:45 PM ISTHyderabad: Gland Pharma Limited, a generic injectable and ophthalmic-focused pharmaceutical company, has received approval from the United States Food...
Entresto Patent Expiry to Weigh on Novartis as Profit Seen Falling in 2026 sheeba farhat6 Feb 2026 11:30 AM ISTNew Delhi: Novartis forecast its first annual drop in operating profit in a decade on Wednesday, even as it indicated that long ‌term, the company...
